Visser, Margaretha M. http://orcid.org/0000-0003-0216-4028
Vangoitsenhoven, Roman http://orcid.org/0000-0003-3523-669X
Gillard, Pieter http://orcid.org/0000-0001-9111-4561
Mathieu, Chantal http://orcid.org/0000-0002-4055-5233
Article History
Accepted: 29 May 2024
First Online: 6 June 2024
Declarations
:
: UZ Leuven received non-financial support for travel from Novo Nordisk, and support from Boehringer Ingelheim for MMV. MMV has served on the speakers bureau for Dexcom, and financial compensation for these activities has been received by KU Leuven.RV serves or has served on advisory panels for Boehringer Ingelheim, Eli Lily, and Sanofi. Financial compensation for these activities has been received by KU Leuven. RV has served on the speakers bureau for Menarini, Boehringer Ingelheim, Eli Lily, Goodlife, Novo Nordisk, Prowell, and Sanofi, and financial compensation for these activities has been received by KU Leuven.PG serves or has served on advisory panels for Novo Nordisk, Sanofi-Aventis, Boehringer Ingelheim, Janssen Pharmaceuticals, Roche, Medtronic, Abbott and Bayer. Financial compensation for these activities has been received by KU Leuven. PG serves or has served on the speakers bureaux for Merck Sharp and Dohme, Boehringer Ingelheim, Bayer, Medtronic, Insulet, Novo Nordisk, Abbott, Roche, VitalAire and Dexcom. Financial compensation for these activities has been received by KU Leuven. KU Leuven received non-financial support for travel for PG from Sanofi-Aventis, A. Menarini Diagnostics, Novo Nordisk, Medtronic and Roche.CM serves or has served on advisory panels for Novo Nordisk, Sanofi, Merck Sharp and Dohme, Eli Lilly, Novartis, AstraZeneca, Boehringer Ingelheim, Roche, Medtronic, ActoBio Therapeutics, Pfizer, Imcyse, Insulet, Zealand Pharma, Avotres, Mannkind, Sandoz and Vertex. Financial compensation for these activities has been received by KU Leuven; KU Leuven has also received research support for CM from Medtronic, Imcyse, Novo Nordisk, Sanofi and ActoBio Therapeutics. CM also serves or has served on the speakers bureaux for Novo Nordisk, Sanofi, Eli Lilly, Boehringer Ingelheim, AstraZeneca and Novartis. Financial compensation for these activities has been received by KU Leuven.
: This article is a review that summarizes studies that have been previously published involving human or animal subjects. It does not contain any original experiments with human or animal subjects performed by any of the authors.